FDA.reportPublic FDA data

Epclusa 150 MG / 37.5 MG Oral Pellet

RxCUI
2584199
RxNorm name
Epclusa 150 MG / 37.5 MG Oral Pellet
Display name
Epclusa 150 MG / 37.5 MG Oral Pellet
Full name
Epclusa 150 MG / 37.5 MG Oral Pellet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EpclusaVELPATASVIR AND SOFOSBUVIRGilead Sciences, Inc.7f30631a-ee3b-4cfe-866b-964df3f0a44f2024-06-05Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2584199

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7f30631a-ee3b-4cfe-866b-964df3f0a44fEpclusa 150 MG / 37.5 MG Oral Pellet [PSN] · sofosbuvir 150 MG / velpatasvir 37.5 MG Oral Pellet [Epclusa] [SBD] · Epclusa (sofosbuvir 150 MG / velpatasvir 37.5 MG) Oral Pellet [SY]314These highlights do not include all the information needed to use EPCLUSA safely and effectively. See full prescribing information for EPCLUSA. EPCLUSA ® (sofosbuvir and velpatasvir) tablets, for oral use EPCLUSA ® (sofosbuvir and velpatasvir) oral pellets Initial U.S. Approval: 201620240605